Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs USA Rare Earth Inc. Class A Common Stock (USAR) Price & Performance

Oscar Health IncTrade
USA Rare Earth Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs USA Rare Earth Inc. Class A Common Stock — how do they compare? Oscar Health Inc trades at $34.17 (market cap $10.43B), while USA Rare Earth Inc. Class A Common Stock trades at $10.24 (market cap $4.23B). The key difference: Oscar Health Inc is far larger — about 2.5× USA Rare Earth Inc. Class A Common Stock's market cap, and Oscar Health Inc is trading nearer its 52-week high, USA Rare Earth Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and USA Rare Earth Inc. Class A Common Stock for 0 Days on average.

OSCRUSAR
Market Cap
$10.43B$4.23B
Volume
5,467,40213,677,660
Sector
HealthBasic Materials
52-Week High
$34.32$33.68
52-Week Low
$10.85$10.32
Typical Hold Time
15 Days0 Days
Enterprise Value
$6.79B$2.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

OSCR trades at $33.79, down 0.65% on the day, with strong technical momentum indicated by bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent analyst upgrades to Strong Buy reflect optimism about expanded market opportunities and margin expansion potential.

The stock presents growth potential with consensus price target of $34.75 offering modest upside. Key risks include rising medical costs threatening profitability and competitive ACA market pressures. Institutional interest remains strong with recent purchases, supporting the bullish technical outlook despite RSI indicating potential near-term overbought conditions.

USA Rare Earth Inc. Class A Common Stock

USA Rare Earth (USAR) trades at $11.265, down 4.7% today and near its 52-week low, reflecting persistent sector pressure. The company shows severe financial strain with a net income margin of -2,159.3% and negative cash flow from operations, though analyst consensus remains unanimously bullish with a $34.57 price target. Recent news highlights strategic investments in a $1.2 billion South Carolina facility and a $2.8 billion Brazil acquisition to build a mine-to-magnet supply chain, positioning it for long-term growth amid U.S. critical mineral initiatives.

The stock presents high risk due to extreme losses and cash burn but offers speculative upside if government funding and project milestones materialize. Key risks include execution challenges, reliance on future financing, and sector volatility. Investors should weigh the bullish analyst outlook against the company's current financial instability and macroeconomic headwinds affecting rare earth markets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OSCR

No sentiment data available yet.

USAR
100% Buy0% Sell
Avg holding period · 0 Days

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →

About USA Rare Earth Inc. Class A Common Stock

USA Rare Earth is building an integrated rare earth and permanent magnet supply chain spanning mining, metal and alloy production, and magnet manufacturing, with assets including the Round Top heavy rare earth deposit in Texas, a magnet manufacturing facility in Stillwater, Oklahoma, and metal-and-alloy producer Less Common Metals.

Read more on USAR →